|
1. Ye Li* , Shu-Xiang Cui* , Shi-Yue Sun , Wen-Na Shi , Zhi-Yu Song , Shu-Qing Wang, Xin-Feng Yu, Zu-huaGao, Xian-jun Qu. Chemoprevention of intestinal tumorigenesis by the natural dietary flavonoid myricetin in APCMin/+ mice. oncotarget, 2016, 7(37): 60446-460.
2. Hao Li, Yaodong Liu, Yumin Jiao, AnchenGuo, XiaoxueXu, XianjunQu, Shuo Wang, Jizong Zhao, Ye Li*, Yong Cao*. Resveratrol sensitizes glioblastoma-initiating cells to temozolomide by inducing cell apoptosis and promoting differentiation. Oncol Rep. 2016, 35(1):343-51.
3. Yuming Jiao , Hao Li, Yaodong Liu , AnchenGuo , XiaoxueXu, XianjunQu ,Shuo Wang, Jizong Zhao, Ye Li * and Yong Cao*. Resveratrol Inhibits the Invasion of Glioblastoma-Initiating Cells via Down-Regulation of the PI3K/Akt/NF-κB Signaling Pathway. Nutrients 2015, 7,: 4383-4402;
4. Ye Li, Wenjing Wang, XiaoxueXu, Shiyue Sun, Xian-junQu, {2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-acetic acid methyl ester (MIAM) inhibited human hepatocellular carcinoma growth through upregulation of Sirtuin-3 (SIRT3). Biomed Pharm. 2015, 69: 125–132.
5. Ye Li, Wenjing Wang, XiaoxueXu, Shiyue Sun, XiaoyuXu, Xian-jun Qu. {2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-acetic Acid Methyl Ester Inhibited Hepatocellular Carcinoma Growth in Bel-7402 Cells and Its Resistant Variants by Activation of NOX4 and SIRT3. BioMed Res Int, 2015:491205.
6. Ye Li, Zu-HuaGao, Xian-jun Qu. The adverse effects of sorafenib in patients with advanced cancers. Basic ClinPharmacolToxicol. 2015, 116(3):216-21..
7. Hart SN*, Ye Li *, Nakamoto K, Subileau EA, Steen D, Zhong XB.. A comparison of whole genome gene expression profiles of HepaRG cells and HepG2 cells to primary human hepatocytes and human liver tissues. Drug MetabDispos. 2010, 38(6):988-94.
8. Ye Li, Cui Y, Hart SN, Klaassen CD, Zhong XB. Dynamic patterns of histone methylation are associated with ontogenic expression of the Cyp3a genes during mouse liver maturation. MolPharmacol. 2009 May;75(5):1171-9.
9. Hart SN, Ye Li, Nakamoto K, Wesselman C, Zhong XB. Novel SNPs in cytochrome P450 oxidoreductase. Drug MetabPharmacokinet. 2007,22(4):322-6.
|
